Literature DB >> 7515032

Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopes.

W Helfrich1, P W Koning, T H The, L De Leij.   

Abstract

Western blot analysis proved that all cluster-2 MAbs recognize identical or overlapping disulfide-bond-dependent epitopes, indicating the presence of a disulfide-bond-stabilized EGP-2 domain carrying highly immunodominant non-linear epitopes. The apparent immunodominance of this domain makes it difficult to generate and select antibodies against other potentially useful EGP-2 epitopes. Using PCR, we have generated mutant EGP-2 cDNA (delta EGP-2) from which the coding sequences for a putative immunodominant 6-kDa intra-chain loop structure has been removed. delta EGP-2 transfected COS-7 cells reacted with MM104, an antibody detecting a linear epitope on EGP-2, but were not recognized by any cluster-2 MAb. To generate new anti-EGP-2 antibodies we constructed another mutant EGP-2 protein (delta EGP-2) from which additional domains, irrelevant for antibody generation (signal peptide, trans-membrane and cytoplasmic domains), were removed. delta EGP-2 was introduced in a prokaryotic expression system that adds a polyhistidine affinity tag to the delta EGP-2 N-terminus, making possible one-step purification by immobilized metal-ion-affinity chromatography (IMAC). Western blot analysis showed that sera derived from mice immunized with purified delta EGP-2 had high-titer antibodies to reduced EGP-2 samples. We conclude that the availability of prokaryotic and eukaryotic EGP-2-expression constructs might facilitate the selection of new anti-EGP-2 MAbs otherwise difficult to obtain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515032     DOI: 10.1002/ijc.2910570714

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN: 0898-6924


  4 in total

1.  Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.

Authors:  M Balzar; I H Briaire-de Bruijn; H A Rees-Bakker; F A Prins; W Helfrich; L de Leij; G Riethmüller; S Alberti; S O Warnaar; G J Fleuren; S V Litvinov
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

Authors:  Manon J Winter; Iris D Nagtegaal; J Han J M van Krieken; Sergey V Litvinov
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

3.  Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells.

Authors:  Edwin Bremer; Douwe Samplonius; Bart-Jan Kroesen; Linda van Genne; Lou de Leij; Wijnand Helfrich
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

4.  EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM.

Authors:  Warangkana Chantima; Charin Thepthai; Pornsuk Cheunsuchon; Tararaj Dharakul
Journal:  BMC Cancer       Date:  2017-12-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.